Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Helle Pappot; Christina Bæksted; Ann Knoop; Sandra A. Mitchell; Aase Nissen; Christoffer Johansen

doi:10.1111/tbj.13204

Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Helle Pappot^*, Christina Bæksted, Ann Knoop, Sandra A. Mitchell, Aase Nissen, Christoffer Johansen

^*Corresponding author for this work

Department of Clinical Medicine

5 Citations (Scopus)

Abstract

The Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed by the National Cancer Institute to capture patient self-reports of symptomatic toxicities during cancer treatment. The aim of this short communication is to describe the design of a national study, which examine the effect of using patients’ electronic PRO-CTCAE reporting with real-time feedback to clinicians on treatment events for breast cancer patients receiving adjuvant chemotherapy. The study's end-points are defined as dose reduction, hospitalization, and febrile neutropenia. This is the first report on the impact of PRO-CTCAE in a national breast cancer population during chemotherapy treatment.

Original language	English
Journal	Breast Journal
Volume	25
Issue number	2
Pages (from-to)	269-272
Number of pages	4
ISSN	1075-122X
DOIs	https://doi.org/10.1111/tbj.13204
Publication status	Published - 2019

Keywords

adjuvant chemotherapy
breast cancer
patient reported outcome
PRO-CTCAE
toxicity

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/tbj.13204

Fingerprint

Dive into the research topics of 'Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)'. Together they form a unique fingerprint.

Cite this

Pappot, H., Bæksted, C., Knoop, A., Mitchell, S. A., Nissen, A., & Johansen, C. (2019). Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE). Breast Journal, 25(2), 269-272. https://doi.org/10.1111/tbj.13204

Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE). / Pappot, Helle; Bæksted, Christina; Knoop, Ann et al.
In: Breast Journal, Vol. 25, No. 2, 2019, p. 269-272.

Research output: Contribution to journal › Journal article › Research › peer-review

Pappot, H, Bæksted, C, Knoop, A, Mitchell, SA, Nissen, A & Johansen, C 2019, 'Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)', Breast Journal, vol. 25, no. 2, pp. 269-272. https://doi.org/10.1111/tbj.13204

Pappot H, Bæksted C, Knoop A, Mitchell SA, Nissen A, Johansen C. Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE). Breast Journal. 2019;25(2):269-272. doi: 10.1111/tbj.13204

Pappot, Helle ; Bæksted, Christina ; Knoop, Ann et al. / Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE). In: Breast Journal. 2019 ; Vol. 25, No. 2. pp. 269-272.

@article{b95a46cadbcd49b6a185be1c947ddafe,

title = "Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)",

abstract = "The Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed by the National Cancer Institute to capture patient self-reports of symptomatic toxicities during cancer treatment. The aim of this short communication is to describe the design of a national study, which examine the effect of using patients{\textquoteright} electronic PRO-CTCAE reporting with real-time feedback to clinicians on treatment events for breast cancer patients receiving adjuvant chemotherapy. The study's end-points are defined as dose reduction, hospitalization, and febrile neutropenia. This is the first report on the impact of PRO-CTCAE in a national breast cancer population during chemotherapy treatment.",

keywords = "adjuvant chemotherapy, breast cancer, patient reported outcome, PRO-CTCAE, toxicity",

author = "Helle Pappot and Christina B{\ae}ksted and Ann Knoop and Mitchell, {Sandra A.} and Aase Nissen and Christoffer Johansen",

year = "2019",

doi = "10.1111/tbj.13204",

language = "English",

volume = "25",

pages = "269--272",

journal = "Breast Journal",

issn = "1075-122X",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)

AU - Pappot, Helle

AU - Bæksted, Christina

AU - Knoop, Ann

AU - Mitchell, Sandra A.

AU - Nissen, Aase

AU - Johansen, Christoffer

PY - 2019

Y1 - 2019

N2 - The Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed by the National Cancer Institute to capture patient self-reports of symptomatic toxicities during cancer treatment. The aim of this short communication is to describe the design of a national study, which examine the effect of using patients’ electronic PRO-CTCAE reporting with real-time feedback to clinicians on treatment events for breast cancer patients receiving adjuvant chemotherapy. The study's end-points are defined as dose reduction, hospitalization, and febrile neutropenia. This is the first report on the impact of PRO-CTCAE in a national breast cancer population during chemotherapy treatment.

AB - The Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed by the National Cancer Institute to capture patient self-reports of symptomatic toxicities during cancer treatment. The aim of this short communication is to describe the design of a national study, which examine the effect of using patients’ electronic PRO-CTCAE reporting with real-time feedback to clinicians on treatment events for breast cancer patients receiving adjuvant chemotherapy. The study's end-points are defined as dose reduction, hospitalization, and febrile neutropenia. This is the first report on the impact of PRO-CTCAE in a national breast cancer population during chemotherapy treatment.

KW - adjuvant chemotherapy

KW - breast cancer

KW - patient reported outcome

KW - PRO-CTCAE

KW - toxicity

U2 - 10.1111/tbj.13204

DO - 10.1111/tbj.13204

M3 - Journal article

C2 - 30761667

AN - SCOPUS:85061456159

SN - 1075-122X

VL - 25

SP - 269

EP - 272

JO - Breast Journal

JF - Breast Journal

IS - 2

ER -